Michael Helmrath · In Vivo Model of Small Intestine
Follow
Article1 min read·Published Jan 2017Older

In Vivo Model of Small Intestine

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Jan 2017 · 1 min read

In brief

In brief

This protocol describes orthotopic transplantation of human pluripotent stem cell-derived intestinal organoids into immunocompromised mice to create functional in vivo models of human small intestine. The technique enables researchers to study intestinal development, physiology, and disease mechanisms using bioengineered human tissue in a living system.

Written by the GCMD Library team from the article.

Michael Helmrath

The utilization of human pluripotent stem cells (hPSCs) offers new avenues in the generation of organs and opportunities to understand development and diseases. The hPSC-derived human intestinal organoids (HIOs) provide a new tool to gain insights in small intestinal development, physiology, and associated diseases. Herein, we provide a method for orthotropic transplantation of HIOs in immunocompromised mice. This method highlights the specific steps to successful engraftment and provides insight into the study of bioengineered human small intestine.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →